Circulating proteomic signatures of chronological age

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 70, Issue 7, 2015, Pages 809-816

  Menni, Cristina ^a   Kiddle, Steven J ^b,c   Mangino, Massimo ^a   Viñuela, Ana ^a   Psatha, Maria ^a   Steves, Claire ^a   Sattlecker, Martina ^b,d   Buil, Alfonso ^e   Newhouse, Stephen ^b,d   Nelson, Sally ^f   Williams, Stephen ^f   Voyle, Nicola ^b,c   Soininen, Hilkka ^g   Kloszewska, Iwona ^h   Mecocci, Patrizia ⁱ   Tsolaki, Magda ^j   Vellas, Bruno ^k   Lovestone, Simon ^l   Spector, Tim D ^a   Dobson, Richard ^b,d   Valdes, Ana M ^a,m   more..

^a ST THOMAS HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d King s College London   (United Kingdom)

^e UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^f SomaLogic Inc   (United States)

^g KUOPIO UNIVERSITY HOSPITAL   (Finland)

^h MEDICAL UNIVERSITY OF LODZ   (Poland)

ⁱ UNIVERSITY OF PERUGIA   (Italy)

^j ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^k UNIVERSITÉ DE TOULOUSE   (France)

^l UNIVERSITY OF OXFORD   (United Kingdom)

^m UNIVERSITY OF NOTTINGHAM   (United Kingdom)

more..

Author keywords

Aging; Aptamers; Blood biomarkers; Early development; Nucleotide; Proteomics

Indexed keywords

BIOLOGICAL MARKER; CARRIER PROTEIN; CHRDL1 PROTEIN, HUMAN; CYTOKINE; EYE PROTEIN; MACROPHAGE ELASTASE; NERVE PROTEIN; PLEIOTROPHIN; SOMATOMEDIN BINDING PROTEIN 6;

ADULT; AGED; AGING; BLOOD; COHORT ANALYSIS; FEMALE; HUMAN; MALE; MIDDLE AGED; PHENOTYPE; PROTEOMICS; REGISTER; TWINS; UNITED KINGDOM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AGING; BIOMARKERS; CARRIER PROTEINS; COHORT STUDIES; CYTOKINES; EYE PROTEINS; FEMALE; GREAT BRITAIN; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 6; MALE; MATRIX METALLOPROTEINASE 12; MIDDLE AGED; NERVE TISSUE PROTEINS; PHENOTYPE; PROTEOMICS; REGISTRIES; TWINS;

EID: 84936743150     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glu121     Document Type: Article

References (43)

1. Fontana L, Partridge L, Longo VD. Extending healthy life span-from yeast to humans. Science. 2010; 328: 321-326. doi: 10.1126/science.1172539
2. Valdes AM, Glass D, Spector TD. Omics technologies and the study of human ageing. Nat Rev Genet. 2013; 14: 601-607. doi: 10.1038/nrg3553
3. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med. 2008; 359: 61-73. doi: 10.1056/NEJMra0708473
4. Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014; 69: S4-S9. doi: 10.1093/gerona/glu057
5. Richardson AG, Schadt EE. The role of macromolecular damage in aging and age-related disease. J Gerontol A Biol Sci Med Sci. 2014; 69: S28-S32. doi: 10.1093/gerona/glu056
6. Morimoto RI, Cuervo AM. Proteostasis and the aging proteome in health and disease. J Gerontol A Biol Sci Med Sci. 2014; 69: S33-S38. doi: 10.1093/gerona/glu049
7. Krištic J, Vuckovic F, Menni C, et al. Glycans are a novel biomarker of chronological and biological ages. J Gerontol A Biol Sci Med Sci. 2014; 69: 779-789. doi: 10.1093/gerona/glt190
8. Menni C, Kastenmüller G, Petersen AK, et al. Metabolomic markers reveal novel pathways of ageing and early development in human populations. Int J Epidemiol. 2013; 42: 1111-1119. doi: 10.1093/ije/dyt094
9. Ignjatovic V, Lai C, Summerhayes R, et al. Age-related differences in plasma proteins: how plasma proteins change from neonates to adults. PLoS ONE. 2011; 6: e17213. doi: 10.1371/journal.pone.0017213
10. Lu J, Huang Y, Wang Y, et al. Profiling plasma peptides for the identification of potential ageing biomarkers in Chinese Han adults. PLoS ONE. 2012; 7: e39726. doi: 10.1371/journal.pone.0039726
11. Baird GS, Nelson SK, Keeney TR, et al. Age-dependent changes in the cerebrospinal fluid proteome by slow off-rate modified aptamer array. Am J Pathol. 2012; 180: 446-456. doi: 10.1016/j.ajpath.2011.10.024
12. Gold L, Ayers D, Bertino J, et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS ONE. 2010; 5: e15004. doi: 10.1371/journal.pone.0015004
13. Lourdusamy A, Newhouse S, Lunnon K, et al. Identification of cis-regulatory variation influencing protein abundance levels in human plasma. Hum Mol Genet. 2012; 21: 3719-3726. doi: 10.1093/hmg/dds186
14. Sattlecker M, Kiddle SJ, Newhouse S, et al. Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology. Alzheimers Dement. 2014. doi: 10.1016/j.jalz.2013.09.016
15. Kiddle SJ, Sattlecker M, Proitsi P, et al. Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study. J Alzheimers Dis. 2014; 38: 515-531. doi: 10.3233/JAD-130380
16. Brown AA, Buil A, Viñuela A, et al. Genetic interactions affecting human gene expression identified by variance association mapping. Elife. 2014; 3: e01381. doi: 10.7554/eLife.01381
17. Han B, Eskin E. Random-effects model aimed at discovering associations in meta-analysis of genome-wide association studies. Am J Hum Genet. 2011; 88: 586-598. doi: 10.1016/j.ajhg.2011.04.014
18. Bates D, Maechler M, Bolker B. lme4: linear mixed-effects models using S4 classes. R package version 0.999375-41. 2011
19. Neale M, Cardon L. Methodology for Genetic Studies of Twins and Families. Dordrecht: Kluwer Academic Publishers; 1992
20. D'Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008; 117: 743-753. doi: 10.1161/CIRCULATIONAHA.107.699579
21. Brooks-Wilson AR. Genetics of healthy aging and longevity. Hum Genet. 2013; 132: 1323-1338. doi: 10.1007/s00439-013-1342-z
22. Larman BW, Karolak MJ, Adams DC, Oxburgh L. Chordin-like 1 and twisted gastrulation 1 regulate BMP signaling following kidney injury. J Am Soc Nephrol. 2009; 20: 1020-1031. doi: 10.1681/ASN.2008070768
23. Kane R, Godson C, O'Brien C Chordin-like 1, a bone morphogenetic protein-4 antagonist, is upregulated by hypoxia in human retinal pericytes and plays a role in regulating angiogenesis. Mol Vis. 2008; 14: 1138-1148
24. Ptitsyn AA, Weil MM, Thamm DH. Systems biology approach to identification of biomarkers for metastatic progression in cancer. BMC Bioinformatics. 2008; 9: S8. doi: 10.1186/1471-2105-9-S9-S8
25. Zmuda JM, Yerges-Armstrong LM, Moffett SP, et al. Genetic analysis of vertebral trabecular bone density and cross-sectional area in older men. Osteoporos Int. 2011; 22: 1079-1090. doi: 10.1007/s00198-010-1296-0
26. Mencej-Bedrac S, Preželj J, Komadina R, Vindišar F, Marc J. -1227C>T polymorphism in the pleiotrophin gene promoter influences bone mineral density in postmenopausal women. Mol Genet Metab. 2011; 103: 76-80. doi: 10.1016/j.ymgme.2011.01.017
27. Papadimitriou E, Mikelis C, Lampropoulou E, et al. Roles of pleiotrophin in tumor growth and angiogenesis. Eur Cytokine Netw. 2009; 20: 180-190. doi: 10.1684/ecn.2009.0172
28. Muramatsu H, Zou P, Kurosawa N, et al. Female infertility in mice deficient in midkine and pleiotrophin, which form a distinct family of growth factors. Genes Cells. 2006; 11: 1405-1417. doi: 10.1111/j.1365-2443.2006.01028.x
29. Li G, Bunn JR, Mushipe MT, He Q, Chen X. Effects of pleiotrophin (PTN) over-expression on mouse long bone development, fracture healing and bone repair. Calcif Tissue Int. 2005; 76: 299-306. doi: 10.1007/s00223-004-0145-6
30. Masuda H, Tsujimura A, Yoshioka M, et al. Bone mass loss due to estrogen deficiency is compensated in transgenic mice overexpressing human osteoblast stimulating factor-1. Biochem Biophys Res Commun. 1997; 238: 528-533. doi: 10.1006/bbrc.1997.7188
31. Hashimoto-Gotoh T, Ohnishi H, Tsujimura A, et al. Bone mass increase specific to the female in a line of transgenic mice overexpressing human osteoblast stimulating factor-1. J Bone Miner Metab. 2004; 22: 278-282. doi: 10.1007/s00774-003-0485-8
32. Li F, Tian F, Wang L, Williamson IK, Sharifi BG, Shah PK. Pleiotrophin (PTN) is expressed in vascularized human atherosclerotic plaques: IFN-{gamma}/JAK/STAT1 signaling is critical for the expression of PTN in macrophages. FASEB J. 2010; 24: 810-822. doi: 10.1096/fj.09-140780
33. Consortium TCADCDG. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet. 2011; 43: 339-344. doi: 10.1038/ng.782
34. Bach LA, Fu P, Yang Z. Insulin-like growth factor-binding protein-6 and cancer. Clin Sci. 2013; 124: 215-229. doi: 10.1042/CS20120343
35. Cui J, Ma C, Qiu J, et al. A novel interaction between insulin-like growth factor binding protein-6 and the vitamin D receptor inhibits the role of vitamin D3 in osteoblast differentiation. Mol Cell Endocrinol. 2011; 338: 84-92. doi: 10.1016/j.mce.2011.03.011
36. Qiu J, Ma XL, Wang X, Chen H, Huang BR. Insulin-like growth factor binding protein-6 interacts with the thyroid hormone receptor a1 and modulates the thyroid hormone-response in osteoblastic differentiation. Mol Cell Biochem. 2012; 361: 197-208. doi: 10.1007/s11010-011-1104-y
37. Micutkova L, Diener T, Li C, et al. Insulin-like growth factor binding protein-6 delays replicative senescence of human fibroblasts. Mech Ageing Dev. 2011; 132: 468-479. doi: 10.1016/j.mad.2011.07.005
38. Chen Z, Seo JY, Kim YK, et al. Heat modulation of tropoelastin, fibrillin-1, and matrix metalloproteinase-12 in human skin in vivo. J Invest Dermatol. 2005; 124: 70-78. doi: 10.1111/j.0022-202X.2004.23550.x
39. Liu Y, Zhang M, Hao W, et al. Matrix metalloproteinase-12 contributes to neuroinflammation in the aged brain. Neurobiol Aging. 2013; 34: 1231-1239. doi: 10.1016/j.neurobiolaging.2012.10.015
40. Hu H, Zhao Y, Xiao Y, Zhang R, Song H. Disruption of plasminogen activator inhibitor-1 gene enhances spontaneous enlargement of mouse airspace with increasing age. Tohoku J Exp Med. 2010; 222: 291-296
41. Ganz P, Stewart A, Farzaneh-Far R, et al. Stratification of cardiovascular risk using an unbiased proteomic approach. Circulation 2012; 126: A14794
42. Vogel C, Marcotte EM. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet. 2012; 13: 227-232. doi: 10.1038/nrg3185
43. Loffredo FS, Steinhauser ML, Jay SM, et al. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell. 2013; 153: 828-839. doi: 10.1016/j.cell.2013.04.015